Author: Bitter I. Dossenbach M.R.K. Brook S. Feldman P.D. Metcalfe S. Gagiano C.A. Furedi J. Bartko G. Janka Z. Banki C.M. Kovacs G. Breier A. for the Olanzapine HGCK Study Group
Publisher: Elsevier
ISSN: 0278-5846
Source: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol.28, Iss.1, 2004-01, pp. : 173-180
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Drugs & Therapy Perspectives, Vol. 23, Iss. 10, 2007-10 ,pp. :
Ziprasidone effective in treatment-resistant schizophrenia
Inpharma, Vol. 1, Iss. 1522, 2006-01 ,pp. :
Olanzapine pamoate for the treatment of schizophrenia
By Naber Dieter
Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 4, 2011-03 ,pp. :